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Objective: In human articular cartilage, tenascin-C (TN-C) expression decreases during maturation of
chondrocytes, and almost disappears in adults; however, it reappears in damaged cartilage. To examine
the effects of TN-C on cartilage degeneration and repair, we compared articular cartilage degeneration
between wild-type (WT) and tenascin-C knockout mouse (TNKO) mice using a spontaneous osteoar-
thritis (OA) in aged joints and surgical OA model. In addition, we made full-thickness cartilage defects
and compared the cartilage repair process between the two groups.
Methods: The surgical procedure to create degenerative OA model was performed by transecting the
anterior cruciate ligament and medial collateral ligament. Full-thickness defects were created in the
center of the femoral trochlea to evaluate cartilage repair. Sections of cartilage were stained with
hematoxylin and eosin or safranin-O, and immunostaining for TN-C. The degrees of degeneration and
repair were graded.
Results: In the WT surgical OA model, the articular cartilage was almost normal at 2 weeks, but safranin-O
decreased staining at 4 weeks. In TNKO mice, safranin-O decreased staining at 2 weeks, and cartilage was
injured intensely at 4 weeks.
In the cartilage repair model, TN-C was expressed after 1 week, was strongly expressed in the upper layer
of regenerated tissue after 3 weeks, and disappeared after 6 weeks. The defects were restored until 6
weeks in WT mice; however, defects in TNKO mice were ﬁlled with ﬁbrous tissue with no cartilage-like
tissue.
Conclusions: This study revealed that cartilage repair in TNKO mice was signiﬁcantly slower than that in
WT mice and that the deﬁciency of TN-C progressed during cartilage degeneration.
 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Tenascin-C (TN-C) is a member of the extracellular matrix
glycoprotein family and is expressed during embryogenesis.
Although its expression is repressed in normal adult tissues, it
reappears under pathological conditions such as inﬂammation,
infection, and tumorigenesis1,2,3,4. In lesions, TN-C promotes
migration and proliferation of parenchymal and/or stromal cells5,6.
Chiquet et al. ﬁrst indicated that TN-C may participate in
chondrogenesis and cartilage development7,8. In subsequent
studies, it was found that TN-C was expressed in early mesen-
chymal condensations of cartilage, progressively disappeared withMasahiro Hasegawa, Depart-
te School of Medicine, 2e174
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s Research Society International. Pthe accumulation of mature cartilage, and disappeared almost
completely in adult articular cartilage; however, it was retained in
the perichondrium, which provides a source of cells to differentiate
into chondroblasts9,10. In addition, TN-C reappears at high levels in
diseased joints, including those with osteoarthritis (OA) and
rheumatoid arthritis (RA)11,12.
Two groups have independently produced tenascin-C knockout
mouse (TNKO) mice13,14. These mice were born alive and, originally,
were described as showing no abnormalities. However, recent
studies have shown that TNKOmice have several problems, such as
abnormal behavior, abnormal brain chemistry15,16, defects in the
structure and repair of neuromuscular junctions17, and defective
recovery from snake venom-induced glomerulonephritis18 and
chemically induced dermatitis19. In addition, we demonstrated
reduced neointimal hyperplasia after vascular surgery20, decreased
myoﬁbroblast recruitment in granulation tissue after myocardial
injury21, and reduced ﬁbrotic change in immuno-mediated
hepatitis22.ublished by Elsevier Ltd. All rights reserved.
N. Okamura et al. / Osteoarthritis and Cartilage 18 (2010) 839e848840We compared articular cartilage degeneration between wild-
type (WT) and TNKO mice using a spontaneous OA in aged joints
and surgical OAmodel to examine the effects of TN-C expression on
cartilage degeneration and repair. In addition, we made full-thick-
ness cylindrical defects in the articular cartilage in the center of the
femoral trochlea and compared the cartilage repair process
between the two groups.
Materials and methods
Animals
Male TNKO and WT littermates of the BALB/c strain were used
and maintained according to guidelines approved by the Mie
University Animal Experiment and Care Committee.
Histological and pathological assessment of young and aged mice
Complete necropsies were performed on male 8-week-old
TNKO (n¼ 4) and WT (n¼ 4) mice and on male 24-week-old TNKO
(n¼ 4) and WT (n¼ 4) mice. Mice were sacriﬁced by cervical
dislocation. Examinations at necropsy included macroscopic
observations, determination of body weight and tail length, and
radiographs. At sacriﬁce, we obtained 12 tissue samples per mouse
(brain, knee joint, vertebrae, spinal cord, kidney, liver, heart, lung,
skin, bone, muscle, and growth plate) for histological analysis.
Spontaneous OA in aged joints model
During breeding and experiments, 24 WT and 24 TNKO mice
were housed in sterilized microbarrier units under germ-free
conditions. Mice received autoclaved chow and acidiﬁed water ad
libitum. Thesemicewere sacriﬁced by cervical dislocation at the age
of 2months (n¼ 6WTand 6 TNKOmice), 4 months (n¼ 6WTand 6
TNKOmice), 6 months (n¼ 6WTand 6 TNKOmice), and 12months
(n¼ 6 WT and 6 TNKO mice). In all cases, the distal femoral chon-
dyle was removed.
OA model
The surgical procedure to create an experimental OA model was
performed on 8-week-old mice. 8 weeks is a standard time point
for knee joint surgery in mice because the trochlear groove is of
adequate size at this age23,24. Eight TNKO mice (n¼ 16 knees) and
nine WT mice (n¼ 18 knees) were anesthetized with an intra-
muscular injection of sodium pentobarbital (0.05 mg/g body
weight). Both knee joints were exposed following amedial capsular
incision and gentle lateral displacement of the extensor muscle,
without transection of the patellar ligament. Then, the anterior
cruciate ligament and medial collateral ligament were transected
using a surgical microscope and microsurgical technique. After
replacement of the extensor muscle, the articular capsule and skin
were independently closed with 6e0 nylon sutures. All mice were
allowed to walk freely without any splintage. WT and TNKO mice
were sacriﬁced by cervical dislocation at 1 week (n¼ 6 WT and 4
TNKO mice), 2 weeks (n¼ 6 WT and 6 TNKO mice), or 4 weeks
(n¼ 6 WT and 6 TNKO mice) after surgery.
Surgical procedures for full-thickness articular cartilage defects
Thirty-two TNKO mice (n¼ 64 knees) and 50 WT mice (n¼ 100
knees) were anesthetized with an intramuscular injection of
sodium pentobarbital (0.05 mg/g body weight). Both knee joints
were approached by means of a medial parapatellar incision
(10 mm) under sterile conditions. The patella was laterallydislocated to expose the articular surface on the femoral trochlea.
Full-thickness cylindrical defects were created in the center of the
femoral trochlea with a hand micro-drill equipped with a 0.3-mm-
diameter drill-bit. After creating the defects, the articular capsule
and skin were independently closed with 6e0 nylon sutures. All
mice were allowed to walk freely without any splintage. WT and
TNKO mice were sacriﬁced by cervical dislocation at 1 day (n¼ 2
WT and two TNKO mice), 1 week (n¼ 5 WT and four TNKO mice), 2
weeks (n¼ 6WTand twoTNKOmice), 3 weeks (n¼ 18WTand nine
TNKO mice), 6 weeks (n¼ 12 WT and 10 TNKO mice), or 12 weeks
(n¼ 7 WT and ﬁve TNKO mice) after creation of defects.Immunohistochemistry for assessment
At the indicated time points, the mice were killed, and the distal
femoral chondyle was removed. All tissues were then ﬁxed in 10%
neutral buffered formalin at room temperature for 2 days, decal-
ciﬁed with 10% ethylenediamine tetraacetic acid for 7 days, and
embedded in parafﬁn. A minimum of ﬁve sagittal and transectional
sections (3 mm thick) were prepared from the center of medial
femoral condyle for assessment of OA and a minimum of ﬁve
sagittal sections (3 mm thick) were prepared from the center of each
defect so that the sampling error could be minimized for assess-
ment of cartilage repair. Sections were stained with hematoxylin
and eosin or safranin-O. The production, characterization, and
immunostaining technique of the anti-TN-C polyclonal rabbit
antibody have been described previously25. Brieﬂy, sections were
incubated in methanol containing 0.3% H2O2 for 30 min to block
intrinsic peroxidase activity and then treated with 0.04% proteinase
K (Sigma-Aldrich, St Louis, MO, USA)/0.1 M PBS solution for 10 min
at 37C to retrieve the antigens, followed by an overnight incuba-
tion with the primary antibody (1 mg/ml) at 4C. After washing,
sections were incubated with peroxidase-conjugated anti-rabbit
IgG Fab’ (1:100 dilution; DAKO, Glostrup, Denmark) for 1 h at 37C.
Finally, the immune reaction was developed with dia-
minobenzidine/H2O2 solution. The immunostaining procedure of
type II collagen was performed using a standard technique (His-
toﬁne mouse stain kit; Nichirei Co., Tokyo, Japan) to block intrinsic
mouse immunoglobulin activity. The sections were incubated in
methanol containing 0.3% H2O2 for 30 min to block intrinsic
peroxidase activity and then treated with 0.04% proteinase K
(Sigma-Aldrich)/0.1 M PBS solution for 10 min at 37C. After
washing, sections were treated with Histoﬁne blocking reagent A
for 60 min at 37C, followed by an overnight incubation with the
primary antibody (1 mg/ml) at 37C. After washing, sections were
treated with Histoﬁne blocking reagent B for 10 min at 37C. After
washing, the sections were incubated with Histoﬁne simple stain
mouse MAX-PO (Nichirei Co., Tokyo, Japan) for 60 min at 37C.
Finally, color was developed with diaminobenzidine/H2O2 solution.Histological grading score for assessment of OA
Sections were evaluated blindly by three independent investi-
gators using the histological grading score of Mankin26, modiﬁed as
described previously27. The total score ranges from 0 to 14 and
includes scores from four categories: cartilage anatomy, cellular
abnormality, matrix staining, and tidemark integrity. Cartilage
anatomy was graded from 0 (normal tissue) to 6 (cartilaginous
tissue with complete loss of cellular organization, clusters of cells,
and osteoclastic activity). Cellular abnormality was graded from
0 (normal tissue) to 3 (hypercellularity). Matrix staining (with
safranin-O) was graded from 0 (normal tissue or slightly decreased
staining) to 4 (unstained). Tidemark integrity was graded from
0 (intact) to 1 (destruction). Based on the sum of the scores, each
Fig. 1. Histological appearance of cartilage tissue in TNKO mice at 24 weeks (original
magniﬁcation 100). Cartilage tissue in TNKO mice was not histologically different
from that in WT mice. A: hematoxylin and eosin stain; B: safranin-O stain; C: type II
collagen immunostaining.
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mild, 3e6; moderate, 7e10; or severe, 11e14.
Histological grading score for assessment of cartilage repair
Sections were evaluated blindly by three independent investi-
gators using the modiﬁed WAKITANI score28. In the modiﬁed
WAKITANI score, safranin-O staining is used instead of toluidine
blue. The WAKITANI score ranges from 0 to 14 and includes scores
from ﬁve categories29: cell morphology, matrix staining, surface
regularity, cartilage thickness, and integration of donor cartilage.
Cell morphology was graded from 0 (for tissue that was normal,
compared with the adjacent, uninjured cartilage) to 4 points
(absence of cartilaginous tissue). Matrix staining, or the degree of
metachromatic staining with safranin-O, was graded from 0 (for
tissue that was normal, compared with the adjacent, uninjured
cartilage) to 3 points (no metachromatic staining). Surface regu-
larity, or the proportion of the surface of the defects that appears
smooth compared with the entire surface, was graded from
0 (when more than three quarters of the surface was smooth) to 3
points (when less than one quarter was smooth). Cartilage thick-
ness, that is, the average thickness of the cartilage in the defects
compared with that of the surrounding cartilage, was graded from
0 (when the average thickness of the cartilage in the defects was
more than two thirds that of the surrounding cartilage) to 2 points
(when the average thickness was less than one third that of the
surrounding cartilage). Integration of donor cartilage with the host
adjacent cartilage was graded from 0 (no gap between donor and
host cartilage) to 2 points (a complete lack of integration, referred
to as dissociation).
Statistical analysis
The nonparametric ManneWhitney U-test (Statview 5.0, Cary,
NC) was used to compare histological grading scores of TNKO and
WT mice at each period. A P-value <0.05 was considered
signiﬁcant.
Results
Gross and histological assessment of TNKO mice
Analysis of gross appearance and radiographs revealed no
signiﬁcant differences betweenWTand TNKOmice at either 8 or 24
weeks of age. Bodyweight at 8 and 24weeks did not differ between
WT and TNKO mice (26.7 3.4 g vs 26.2 2.7 g, respectively, at 8
weeks; P¼ 0.773, and 33.4 2.3 g vs 33.8 1.5 g, respectively, at 24
weeks; P¼ 0.564). The tail length at 8 and 24 weeks did not differ
between groups (9.6 0.5 cm vs 9.7 0.6 cm, respectively, at 8
weeks; P¼ 0.884, and 10.6 0.2 cm vs 10.4 0.5 cm, respectively,
at 24 weeks; P¼ 0.885) in WT and TNKO mice. In addition, all
tissues examined were histologically normal (Fig. 1), and histo-
logical analysis of a variety of tissues revealed no differences
between WT and TNKO mice. All sections of knee in both WT and
TNKO mice scored 0 points in terms of histological grading using
the modiﬁed WAKITANI and Mankin score.
Aging-dependent development of OA
In WT and TNKO mice, the articular cartilage of all mice was
almost normal at 2, 4, and 6 months [Fig. 2(a) AeI, MeR]. However,
at the age of 12 months, TNKO mice showed strong degeneration
that sometimes included large cartilage defects and ﬁbrillation
[Fig. 2(a) S, T]. In contrast, WT mice showed slight degeneration,
irregular cartilage surface, and slightly decreased safranin-Ostaining [Fig. 2(a) J, K]. TN-C immunostaining was found in the thin
layer at the surface of cartilage [Fig. 2(a), L] only at the age of 12
months.Progression of OA in WT and TNKO surgical OA model mice
In WT and TNKO mice, articular cartilage was almost normal,
although some cartilage showed irregular surface areas and cell
clusters at 1 week [Fig. 3(A, B, H, I)]. There were no differences
between 1 week and 2 weeks in WT mice [Fig. 3(C, D)], but
safranin-O decreased staining in TNKOmice at 2 weeks [Fig. 3(J, K)].
At 4 weeks, safranin-O decreased staining inWTmice [Fig. 3(EeG)],
Fig. 2 (a). Histological appearance of cartilage tissues in WT mice at the age of 2 months (AeC), 4 months (DeF), 6 months (GeI), and 12 months (JeL), and in TNKO mice at the age
of 2 months (M, N), 4 months (O, P), 6 months (Q, R), and 12 months (S, T) (A, D, G, J, M, O, Q, S: hematoxylin and eosin stain; B, E, H, K, N, P, R, T: safranin-O stain; C, F, I, L: TN-C
immunostaining). Original magniﬁcation 100 for all stains.The cartilage of all mice was almost completely degenerated until the age of 4 months, and both groups showed
degenerated cartilage at the age of 6 months. However, the degeneration of cartilage in TNKO mice was more conspicuous than that in WT mice at the age of 12 months. (b)
Histological appearance of cartilage tissues of the medial chondyle in WT mice at the age of 2 months (A), 4 months (B), 6 months (C), and 12 months (D), and in TNKO mice at the
age of 2 months (E), 4 months (F), 6 months (G), and 12 months (H) (AeH; safranin-O stain). Original magniﬁcation 40.
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Fig. 3. Histological appearance of cartilage tissues in WT mice at 1 week (A, B), 2 weeks (C, D), and 4 weeks (EeG) after surgery, and in TNKO mice at 1 week (H, I), 2 weeks (J, K),
and 4 weeks (LeN) after surgery (A, C, E, H, J, L: hematoxylin and eosin stain; B, D, F, G, I, K, M, N: safranin-O stain). AeF, HeM: hematoxylin and eosin and safranin-O stain; original
magniﬁcation 100; G, N: original magniﬁcation 40. The cartilage of all mice was slightly degenerated 1 week after surgery. The degeneration in TNKO mice was more
conspicuous than that in WT mice at 2 and 4 weeks after surgery.
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progressed in TNKO mice [Fig. 3(LeN)].
Cartilage repair process in WT and TNKO mice
In WT mice, the deeper halves of the defects were ﬁlled with
blood clots without TN-C expression after 1 day [Fig. 4(B)]. After 1
week, cartilage regeneration started [Fig. 5(A, B)]. TN-C immunos-
taining was observed at the base of the defects and the trabecular
surfaces [Fig. 4(C)]. After 2 weeks, the defects were completely
ﬁlled with ﬁbrous tissue. Safranin-O staining was found in a limitedpart of the regenerated tissue [Fig. 5(C, D)]. In addition, TN-C
expression was seen at the edge of the defects, and was positive in
immature chondrocytes but not in mature chondrocytes stained by
safranin-O [Fig. 4(D) and Fig. 5(D)]. 3 weeks later, the defects were
ﬁlled with regenerated cartilage-like tissue resembling hyaline
cartilage. The cells seemed to be well-differentiated chondrocytes
and were surrounded by metachromatic matrix. However, the
margins of the regenerated cartilage-like tissue were not
completely integrated with adjacent host cartilage, and the
repaired cartilage-like tissue was thicker than normal cartilage
[Fig. 5(E, F)]. TN-C expressionwas observed in the upper layer of the
Fig. 4. TN-C immunostaining of cartilage tissues in WT mice at pre-surgery (A), 1 day (B), 1 week (C), 2 weeks (D), 3 weeks (E), 6 weeks (F), and 12 weeks (G) and in TNKO mice at 3
weeks (H) (original magniﬁcation 100). In WT mice, TN-C expression was found from 1 week after surgery to 3 weeks after surgery, and disappeared after 6 weeks. However, TN-C
reappeared after 12 weeks. In TNKO mice, TN-C expression was not found.
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[Fig. 4(E)]. After 6 weeks, the thickness of the regenerated cartilage
tissuewas reduced to the same size as the adjacent normal cartilage
[Fig. 5(G, H)] and TN-C expression disappeared [Fig. 4(F)]. After 12
weeks, the appearance of the cartilage was comparable with that of
hyaline cartilage, although the regenerated cartilage-like tissuewas
eroded and metachromatic staining was abnormally faint or absent
in some areas [Fig. 5(I, J)]. TN-C reappeared in the thin layer at the
surface of the regenerated cartilage [Fig. 4(G)]
The cartilage repair process in TNKO mice was different from
that inWTmice. After 1 day and 1 week, no difference was found in
cartilage repair between WT and TNKO mice [Fig. 5(K, L)]. After 3and 6 weeks, the defects were completely organized by ﬁbrous
tissue; however, safranin-O staining and regenerated tissue that
resembled hyaline cartilage were not observed. The surface was
also irregular [Fig. 5(OeR)]. After 12 weeks, the defects were not
ﬁlled with the regenerated cartilage-like tissue [Fig. 5(S, T)].
Comparison of histological grading scores in WT and TNKO mice
Figure 6 shows the histological grading scores between groups.
In the spontaneous OA in aged joints model, signiﬁcant differences
were only seen at the age of 12 months. At the age of 2 months, the
score was 0.333 0.52 points in both WT and TNKO mice
Fig. 5. Histological appearance of articular cartilage tissues in WT mice at 1 week (A, B), 2 weeks (C, D), 3 weeks (E, F), 6 weeks (G, H), and 12 weeks (I, J) after surgery, and in TNKO
mice at 1 week (K, L), 2 weeks (M, N), 3 weeks (O, P), 6 weeks (Q, R), and 12 weeks (S, T) after surgery (A, C, E, G, I, K, M, O, Q, S: hematoxylin and eosin stain; B, D, F, H, J, L, N, P, R, T:
safranin-O stain). Original magniﬁcation 100 for all stains. Hematoxylin and eosin or safranin-O stain in TNKO mice was not different from that in WT mice. In WT mice, the
defects were restored by cartilage-like tissue until 6 weeks after surgery. In TNKO mice, the defects were ﬁlled with ﬁbrous tissues without cartilage-like tissue. The deﬁciency of
TN-C appeared to delay articular cartilage repair in mice.
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points in WT mice and 0.500 0.55 points in TNKO mice
(P¼ 0.784). At the age of 6 months, the score was 4.1671.33
points in WT mice and 5.333 2.07 points in TNKO mice
(P¼ 0.276). At the age of 12 months, the score was 5.8331.17
points in WT mice and 9.833 2.56 points in TNKO mice
(P¼ 0.007) [Fig. 6(A)].
In the surgical OA model, 1 week after surgery, the score was
1.750 0.44 points in WT mice and 2.250 0.50 points in TNKO
mice (P¼ 0.312). 2 weeks later, the score was 2.5001.23 points in
WTmice and 4.5001.52 points in TNKOmice (P¼ 0.037). 4 weeks
later, the score was 2.7501.04 points in WTmice and 6.1171.94
points in TNKO mice (P¼ 0.038) [Fig. 6(B)].
In the full-thickness cartilage defects model, 1 day after surgery,
the score was 14 points in both WT and TNKO mice. 1 week later,the score was 12.501.55 points in WT mice and 12.791.02
points in TNKO mice (P¼ 0.838). Two weeks after, the score was
9.47 2.01 points inWTmice and 10.731.14 points in TNKOmice
(P¼ 0.042). Three weeks after surgery, the score was 6.70 3.42
points in WT mice and 10.87 2.39 points in TNKO mice
(P< 0.001). Six weeks after surgery, the scorewas 7.713.72 points
inWTmice and 9.273.01 points in TNKOmice (P¼ 0.018). Twelve
weeks after surgery, the score was 7.861.77 points in WT mice
and 10.27 2.20 points in TNKO mice (P< 0.001) [Fig. 6(C)].
Discussion
TN-C is known to regulate multiple cellular functions during
tissue remodeling. Despite this function, previous studies have
shown that initial examination of TNKO mice revealed no
AB
C
Fig. 6. Histological grading scores for cartilage degeneration and repair of WT mice
and TNKO mice are expressed as the mean of the sum of the scores from each histo-
logical section through the joints (A: Mankin score26 in aging model, B: Mankin score26
in OA model, C: modiﬁed Wakitani score28 for cartilage repair). Error bars indicate
standard deviation. *P< 0.05.
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tissues with the highest expression of TN-C13,14. In this study,
extensive histological evaluation of samples from 12 different
tissues, including articular cartilage obtained from our originally
produced TNKO mice, revealed no indication of developmental or
growth deﬁciencies in TNKO mice.
Other studies have examined the cartilage of TNKO mice30,31.
Immunohistological studies have conﬁrmed that in healthy
articular cartilage, TN-C staining is barely observed in the
superﬁcial and upper-middle zones and is primarily seen in the
territorial matrix of the articular chondrocytes11. In moderate and
severe OA, lesions revealed increased territorial and interterrito-
rial immunostaining, mainly in cartilage areas showing a great
reduction of safranin-O staining9,11,32. In addition, we previously
demonstrated a correlation between levels of TN-C in joint ﬂuids
and OA severity as shown on radiographs33. Thus, results of
previous studies suggest that TN-C plays an important role in thedegeneration of articular cartilage. However, it is still unclear if
TN-C has a preventive or healing function in damaged articular
cartilage.
Our results show that expression of TN-C is observed during the
cartilage repair process. Although TN-C was not expressed after 1
day, its expression started 1 week after damage and was increased
in 2 weeks. TN-C was strongly expressed in the upper layer of
regenerated cartilage-like tissue after 3 weeks, and almost dis-
appeared in regenerated mature cartilage 6 weeks later. Mackie et.
al. reported that in full-thickness skin wounds, TN-C staining
became intense after 1 day, was the most intense after 5e7 days,
and disappeared after 10e14 days34. The period of TN-C expression
in regenerated cartilage in our study was longer than that shown in
skin wound healing. Because articular cartilage has a limited
capacity for regeneration, the repair process in articular cartilage
may be slower than that in the skin.
Athough the cartilage defects were almost completely
restored at 6 weeks in WT mice, in TNKO mice, the defects were
ﬁlled with ﬁbrous tissues without cartilage-like tissue at 3
weeks, and immature cartilage tissue remained at 6 weeks. We
clariﬁed that TN-C was expressed at the early phase of the
cartilage repair process and disappeared at the end phase in full-
thickness articular cartilage defects. In addition, cartilage repair
in WT mice was completed earlier than that in TNKO mice. These
results suggest that TN-C is the protein that promotes cartilage
repair.
Our results also showed that in the spontaneous OA in aged
joints model, articular cartilage of TNKO mice degenerated at the
age of 6e12 months and that this process occurred earlier than that
in WT mice. In the surgical OA model, articular cartilage of TNKO
mice degenerated 2 weeks after surgery, and this process occurred
earlier than that in WT mice. These results suggest that TN-C is the
protein that inhibits cartilage degeneration.
OA is characterized by degeneration of cartilage. It is generally
accepted that proinﬂammatory cytokines, including interleukin-1b
(IL-1b) and tumor necrosis factor a (TNF-a), cause loss of cartilage
matrix. Previous studies have shown that TN-C expression is
upregulated by various growth factors and cytokines such as
Transforming growth factor (TGF)b135, basic ﬁbroblast growth
factor36, hepatocyte growth factor37, TNF-a23, and interleukins38. In
particular, IL-1b and TNF-a upregulate TN-C expression in chon-
drocytes of OA cartilage12,39. Our previous study demonstrated that
TNF-a stimulated TN-C expression through nuclear factor-kappa B
(NF-kB) signaling with RelA activation in cultured chondrocytes of
OA32. Previous studies have suggested that the signaling involved in
RelA activation affects cell proliferation40e42. TN-C is also known to
promote proliferation in various cells21,31. These ﬁndings suggest
that deposited TN-C can promote chondrocyte proliferation
through NF-kB signaling in OA cartilage.
TN-C has previously been shown to be associated with the
mesenchymal cell condensation that precedes either chondro-
genesis or intramembranous osteogenesis, and to stimulate chon-
drogenic cell differentiation in chick limb mesenchymal
cultures10,30. TN-C seems to promote the differentiation of chon-
drocytes from mesenchymal cells.
In conclusion, the present study revealed that TN-C expressed at
the early phase of cartilage repair completely disappeared in
regenerated mature cartilage, and reappeared in the thin layer at
the surface of regenerated cartilage with degeneration. Moreover,
the present study revealed that the deﬁciency of TN-C progresses
during cartilage degeneration in the spontaneous OA in aged joints
and surgical OA model. We showed that cartilage repair in full-
thickness cartilage defects in TNKO mice was delayed compared
with WT mice. These results strongly suggest that TN-C promotes
chondrogenesis and cartilage repair in damaged and degenerated
N. Okamura et al. / Osteoarthritis and Cartilage 18 (2010) 839e848 847cartilage. In terms of the reason that TN-C is expressed strongly in
knee OA in human9,11,31,32, we consider that TN-C is expressed at
high levels in conjunctionwith cartilage remodeling such as occurs
with degeneration and repair. Further studies are needed to eval-
uate the effect of TN-C in cartilage.
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